From Postdocs to Innovators with Chris and Pamela Contag:
Co-Founders of Xenogen
Event Date: Wednesday, March 16, 2011 , 5:45 pm to 7:30 pm
Location: Clark Center, room S360 (Behind Peet's Coffee)
Funding for the event is generously provided by the Stanford Office of Technology Licensing (OTL)
Profile of Chris and Pamela Contag
Co-Founders of Xenogen - From Postdocs to Innovators
This AIMS event explores innovation in academia, and the bridge between
industry and the academia.
Chris and Pamela Contag are a husband and wife team, both former Stanford
postdocs. In 1995, they co-founded Xenogen - a life science startup that
created an in vivo imaging system with advanced fluorescent detection
capability to accelerate preclinical drug discovery and development. In
2006, Xenogen was acquired by Caliper Life Science.
After Xenogen, Christopher Contag became assistant professor of Pediatrics
at Stanford University. He is now an Associate Professor of Pediatrics and
the Co-Director of the Molecular Imaging Program at Stanford (MIPS). MIPS is
an inter-disciplinary program that brings together scientists and physicians
who share a common interest in developing and using state-of-the-art imaging
technology and developing molecular imaging assays for studying intact
In contrast, Pamela Contag became a serial entrepreneur. Pam founded a slew
of life-science startups (ConcentRx, Cygnet BioFuels), of which she was also
the CEO (Cobalt Biofuels, ConcentRx). She is now the owner of Cygnet
Biofuels – an integrated energy system start-up.
Chris and Pam have kindly agreed to share their valuable time and insights
on what it takes to be a Postdoc entrepreneur.